IFR Americas ECM Pipeline
February 08, 2019 at 09:10 AM EST
Gossamer Bio (US, biotech) – $276m IPO. 17.3m shares (100% prim) at $16.00 versus $16.00 fixed-price marketing. BAML, SVBL, BARC, EVER. Existing holders indicated for up to $100m. Upsized 20% from 14.4m shares.
